NAM works to change lives by sharing information about HIV and AIDS. We believe independent, clear and accurate information is vital in the fight against HIV and AIDS. More about us >

Copy of Factsheets: Acute & primary infection

We've published two new factsheets on acute and primary HIV infection, and symptoms of seroconversion.

Read about HIV testing after a recent infection, starting treatment and find out what the symptoms are of seroconversion.

Copy of Factsheets: Acute & primary infection

We've published two new factsheets on acute and primary HIV infection, and symptoms of seroconversion.

Read about HIV testing after a recent infection, starting treatment and find out what the symptoms are of seroconversion.

Factsheets: Acute & primary infection

We've published two new factsheets on acute and primary HIV infection, and symptoms of seroconversion.

Read about HIV testing after a recent infection, starting treatment and find out what the symptoms are of seroconversion.

PrEP in Europe Summit 2019: applications open

The second PrEP in Europe Summit is being held in Warsaw, Poland from 10-12 October. The theme of this year's Summit is 'The right to PrEP : Getting PrEP right' – ending unequal access to effective HIV prevention in Europe.

Applications are now open for the Summit. If you are applying for a scholarship, the deadline is 1 July.

Sign up to NAM's HIV update bulletin

Have you signed up to HIV update? Sent out fortnightly, it offers a round-up of the latest HIV news, for people living with HIV in the UK and beyond, giving links to more detailed articles and other sources of information.

Follow us on social media

Keep up to date with all the projects, latest achievements and new developments that are going on in the world of NAM via our Facebook page.

Follow us on Twitter for links to hot off the press news stories from our editors covering key developments and conferences as they happen.

New edition: Antiretroviral drug chart

A new edition of our Antiretroviral drug chart is now available online and in print through our patient information scheme.

This one-page reference guide lists all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.

aidsmap HIV & AIDS news

More news from aidsmap

Editor's picks from other sources

More Editor's picks

E-atlas Peru

Find news, resources and services from Peru
Or select a country from the list below

A to Z of topics

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.